Cargando…

Rapid Emergence of Chronic Lymphocytic Leukemia During JAK2 Inhibitor Therapy in a Patient With Myelofibrosis

Supplemental Digital Content is available in the text

Detalles Bibliográficos
Autores principales: Sousos, Nikolaos, Buck, Gemma, Rodriguez-Meira, Alba, Norfo, Ruggiero, Hamblin, Angela, Pezzella, Francesco, Davies, Jennifer, Hublitz, Philip, Psaila, Bethan, Mead, Adam J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306308/
https://www.ncbi.nlm.nih.gov/pubmed/32647791
http://dx.doi.org/10.1097/HS9.0000000000000356
_version_ 1783548629064089600
author Sousos, Nikolaos
Buck, Gemma
Rodriguez-Meira, Alba
Norfo, Ruggiero
Hamblin, Angela
Pezzella, Francesco
Davies, Jennifer
Hublitz, Philip
Psaila, Bethan
Mead, Adam J.
author_facet Sousos, Nikolaos
Buck, Gemma
Rodriguez-Meira, Alba
Norfo, Ruggiero
Hamblin, Angela
Pezzella, Francesco
Davies, Jennifer
Hublitz, Philip
Psaila, Bethan
Mead, Adam J.
author_sort Sousos, Nikolaos
collection PubMed
description Supplemental Digital Content is available in the text
format Online
Article
Text
id pubmed-7306308
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-73063082020-07-08 Rapid Emergence of Chronic Lymphocytic Leukemia During JAK2 Inhibitor Therapy in a Patient With Myelofibrosis Sousos, Nikolaos Buck, Gemma Rodriguez-Meira, Alba Norfo, Ruggiero Hamblin, Angela Pezzella, Francesco Davies, Jennifer Hublitz, Philip Psaila, Bethan Mead, Adam J. Hemasphere Letter Supplemental Digital Content is available in the text Wolters Kluwer Health 2020-05-27 /pmc/articles/PMC7306308/ /pubmed/32647791 http://dx.doi.org/10.1097/HS9.0000000000000356 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Letter
Sousos, Nikolaos
Buck, Gemma
Rodriguez-Meira, Alba
Norfo, Ruggiero
Hamblin, Angela
Pezzella, Francesco
Davies, Jennifer
Hublitz, Philip
Psaila, Bethan
Mead, Adam J.
Rapid Emergence of Chronic Lymphocytic Leukemia During JAK2 Inhibitor Therapy in a Patient With Myelofibrosis
title Rapid Emergence of Chronic Lymphocytic Leukemia During JAK2 Inhibitor Therapy in a Patient With Myelofibrosis
title_full Rapid Emergence of Chronic Lymphocytic Leukemia During JAK2 Inhibitor Therapy in a Patient With Myelofibrosis
title_fullStr Rapid Emergence of Chronic Lymphocytic Leukemia During JAK2 Inhibitor Therapy in a Patient With Myelofibrosis
title_full_unstemmed Rapid Emergence of Chronic Lymphocytic Leukemia During JAK2 Inhibitor Therapy in a Patient With Myelofibrosis
title_short Rapid Emergence of Chronic Lymphocytic Leukemia During JAK2 Inhibitor Therapy in a Patient With Myelofibrosis
title_sort rapid emergence of chronic lymphocytic leukemia during jak2 inhibitor therapy in a patient with myelofibrosis
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306308/
https://www.ncbi.nlm.nih.gov/pubmed/32647791
http://dx.doi.org/10.1097/HS9.0000000000000356
work_keys_str_mv AT sousosnikolaos rapidemergenceofchroniclymphocyticleukemiaduringjak2inhibitortherapyinapatientwithmyelofibrosis
AT buckgemma rapidemergenceofchroniclymphocyticleukemiaduringjak2inhibitortherapyinapatientwithmyelofibrosis
AT rodriguezmeiraalba rapidemergenceofchroniclymphocyticleukemiaduringjak2inhibitortherapyinapatientwithmyelofibrosis
AT norforuggiero rapidemergenceofchroniclymphocyticleukemiaduringjak2inhibitortherapyinapatientwithmyelofibrosis
AT hamblinangela rapidemergenceofchroniclymphocyticleukemiaduringjak2inhibitortherapyinapatientwithmyelofibrosis
AT pezzellafrancesco rapidemergenceofchroniclymphocyticleukemiaduringjak2inhibitortherapyinapatientwithmyelofibrosis
AT daviesjennifer rapidemergenceofchroniclymphocyticleukemiaduringjak2inhibitortherapyinapatientwithmyelofibrosis
AT hublitzphilip rapidemergenceofchroniclymphocyticleukemiaduringjak2inhibitortherapyinapatientwithmyelofibrosis
AT psailabethan rapidemergenceofchroniclymphocyticleukemiaduringjak2inhibitortherapyinapatientwithmyelofibrosis
AT meadadamj rapidemergenceofchroniclymphocyticleukemiaduringjak2inhibitortherapyinapatientwithmyelofibrosis